Maria E Martinez's most recent trade in Mirati Therapeutics Inc was a trade of 7,520 Non Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 7,500 | 17,500 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.76 per share. | 29 Jan 2021 | 7,500 | 10,975 (0%) | 0% | 39.8 | 298,200 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 203.43 per share. | 29 Jan 2021 | 1,579 | 6,955 (0%) | 0% | 203.4 | 321,219 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 204.43 per share. | 29 Jan 2021 | 1,205 | 5,750 (0%) | 0% | 204.4 | 246,333 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 206.63 per share. | 29 Jan 2021 | 1,100 | 3,675 (0%) | 0% | 206.6 | 227,297 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 205.26 per share. | 29 Jan 2021 | 975 | 4,775 (0%) | 0% | 205.3 | 200,125 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 201.99 per share. | 29 Jan 2021 | 960 | 8,534 (0%) | 0% | 202.0 | 193,911 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 29 Jan 2021 | 719 | 9,956 (0%) | 0% | 200.1 | 143,839 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 200.90 per share. | 29 Jan 2021 | 462 | 9,494 (0%) | 0% | 200.9 | 92,818 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 198.48 per share. | 29 Jan 2021 | 250 | 10,675 (0%) | 0% | 198.5 | 49,621 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 207.82 per share. | 29 Jan 2021 | 200 | 3,475 (0%) | 0% | 207.8 | 41,565 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 197.14 per share. | 29 Jan 2021 | 50 | 10,925 (0%) | 0% | 197.1 | 9,857 | Common Stock |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock |